Time New York: Thu 18 Oct 22:20 pm  |  Save 15% on H&R Block Online

  
caticonslite_bm_alt

Kala Pharmaceuticals (KALA) Catches Eye: Stock Jumps 7.4%

Zacks

Kala Pharmaceuticals, Inc. KALA was a big mover last session, as the company saw its shares rise more than 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company—as the stock is now down 26.8% in the past one-month time frame.

The company has seen no changes when it comes to estimate revision over the past month, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Kala Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

Kala Pharmaceuticals, Inc. Price


Kala Pharmaceuticals, Inc. Price | Kala Pharmaceuticals, Inc. Quote

Investors interested in the Medical – Biomedical and Genetics industry may consider a better-ranked stock like Amgen Inc. AMGN, which carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is KALA going up? Or down? Predict to see what others think:Up or Down

Today's Stocks from Zacks' Hottest Strategies

It's hard to believe, even for us at Zacks. But while the market gained +21.9% in 2017, our top stock-picking screens have returned +115.0%, +109.3%, +104.9%, +98.6%, and +67.1%.
And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 – 2017, the composite yearly average gain for these strategies has beaten the market more than 19X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.

See Them Free>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research
<-- You can share this post with your network,
or give us your opinion and leave a comment.
Be sure to check our RSS feeds for updates.